GlassScriptPhysician profile
Ronwick Lewis
NPI 1629623566
$627.33
in general payments reported to CMS, 2019-2025
11 companies · $268 in 2025
The $268 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $141 · 2023: $136 · 2024: $82.13 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $485.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $129.21 | 2025 | Xiaflex, Aveed |
| Rochester Medical Corporation | $127.67 | 2022 | |
| Boston Scientific Corporation | $83.91 | 2023-2025 | General - Therapies |
| Smith+Nephew, INC. | $52.45 | 2023 | Stravix |
| Urogen Pharma, INC. | $48.24 | 2023-2025 | Jelmyto |
| Teleflex LLC | $45.88 | 2025 | Barrigel |
| Endo Pharmaceuticals INC. | $44.13 | 2023 | Xiaflex, Aveed |
| Medline Industries LP | $30.40 | 2024 | |
| Immunitybio, INC. | $25.94 | 2024 | |
| Progenics Pharmaceuticals, INC. | $25.79 | 2024 | |
| Convatec INC. | $13.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronwick Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.